Barry J. Simon, Director at ImmunityBio, Inc. (IBRX), sold 151,967 shares at $7.88 ($1.1M) on 2026-01-20, disclosed to the SEC on 2026-01-21.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.54 | 76,967 | $503K | 46.0% |
| 2 | $7.88 | 75,000 | $591K | 54.0% |
| Total | $7.20 avg | 151,967 | $1.1M | 100% |
| Filing → |
| IBRX | SELL | 2026-06-05 | $165K | — | Filing → |
| IBRX | SELL | 2026-02-26 | $1.8M | — | Filing → |
| IBRX | SELL | 2026-02-24 | $3.5M | — | Filing → |